scorecardresearch
Sunday, September 21, 2025
TopicCoronavirus vaccine

Topic: coronavirus vaccine

AstraZeneca trial illness likely not linked to Covid vaccine, Oxford says

After safety reviews, Oxford says there is insufficient evidence to say for certain that neurological symptoms developed by volunteers were or were not related to the vaccine.

China approves trials for its first nasal spray coronavirus vaccine

Microbiologist from the University of Hong Kong, Yuen Kwok-yung, said the vaccine stimulates the natural infection pathway of respiratory viruses to activate the immune response.

Still aiming for Oxford Covid vaccine by end of this year, AstraZeneca CEO says

AstraZeneca CEO Pascal Soriot sought to reassure investors after the Oxford vaccine trial was halted due to a person in the UK falling sick, triggering a review of safety data.

Why big pharma needs to do more to counter Covid vaccine politics

9 Covid vaccine developers signed a pledge saying they won't submit their inoculations for Food & Drug Administration approval until they show safety & efficacy in late-stage trial.

The moment of truth for Covid vaccine frontrunners is around the corner

The first results showing whether a vaccine can stop people from getting the virus could come by mid-September from AstraZeneca.

India readying roadmap to ensure Covid vaccine reaches all in ‘shortest time’, ICMR says

In the latest edition of its e-newsletter, ICMR has lauded its own efforts in bolstering India’s testing capacity, saying it ‘has broken the global perception’.

FDA wasn’t wrong in allowing plasma therapy for Covid patients in US

FDA's decision set off a media firestorm, with politicians, public-health officials & medical professionals insisting that the Trump administration was playing politics with science.

UK funds Cambridge University for 1 vaccine that can protect against multiple coronaviruses

Cambridge University aims to use genetic sequences of other known coronaviruses to create one vaccine that goes beyond Covid-19 to fight related diseases.

India to get Covid vaccine by end of year if all goes well, says Harsh Vardhan

Indian Council of Medical Research is in the process of developing an online vaccine portal which will provide information related to Covid-19 vaccine development in India and abroad.

Covid vaccine contender CureVac BV shares soar 249% in US trading debut

CureVac, based in Tubingen, Germany, said in June that it received regulatory approval to begin Phase 1 trials of its vaccine candidate. It said it expects the results in the fourth quarter.

On Camera

Ahmedabad’s Calico Museum took away my phone. And then something magical happened

Without my phone, I wasn't thinking about capturing some beautiful textiles for my ‘inspiration gallery’. I was fully present, taking in the colours and patterns on display.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

60 yrs on, veterans recall lessons from 1965 India-Pakistan war. ‘Equipment alone doesn’t win battles’

A common thread runs through the memories of soldiers of the 1965 war—ingenuity, courage and camaraderie that withstood an apparently technologically superior foe.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.